Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the Arexvy vaccine.

Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval for those aged 12 and up.

Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.

Requirement for prior authorization more common for patients identifying as Black, Hispanic and with non-Medicare insurance.

Increased likelihood seen with high waist circumference and glucose intolerance as well as having 2 or more cardiometabolic risk factors.

Researchers conducted a systematic review and meta-analysis to evaluate the efficacy of immune-inflammatory indices for predicting acute gout attacks.

In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.

The AI tool can review information such as test results, medical history, medications, medical visit notes and data from wearable devices. HealthDay News — Microsoft is rolling out a new artificial ...

Response and remission rates to immunosuppressive therapy was similar in Crohn disease (CD) with upper gastrointestinal (GI) involvement or extensive CD (ECD), according to study ...

Researchers examined the associations between fall risk and bupropion augmentation in older adults with major depressive disorder.

Researchers explore the links between birth control and depression, highlighting potential risks among adolescents.

Researchers examined the effectiveness of human papillomavirus vaccination for the prevention of genital diseases among men in a meta-analysis.